MCL1 and acute myeloid leukemia: In order to probe the effects of JTE-013 on the levels of cellular sphingolipids we treated MV411 AML cells with 10 μM JTE-013, or vehicle (DMSO) control for 6 h, a time we previously demonstrated could result in Mcl-1 degradation13, and then subjected the cells to LC–MS analysis.